Elsight’s (ASX: ELS) Halo platform has been added to the U.S. Department of War’s Defense Contract Management Agency Blue List. This inclusion certifies Halo meets stringent U.S. military standards for operational reliability, cybersecurity, data integrity, and supply chain security. The Blue List serves as a trusted, centralized marketplace that enables U.S. military units to procure vetted technologies rapidly. The milestone is strategically significant as it coincides with a major surge in U.S. defence drone spending, including approximately US$75 billion proposed for drone and counter-drone capabilities in the FY27 budget, positioning Elsight for accelerated adoption and deployment of Halo.

Predictive Discovery (ASX: PDI) reported on its March quarter, post merger with Robex Resources, achieving 48,178oz gold production and its Kiniero Gold Mine in Guinea producing 38,178oz at an all-in sustaining cost of US$1,043/oz as it continues ramp up. PDI guided CY2026 gold production of 198,000-220,000oz from Kiniero and Nampala, with cost guidance to follow in the June quarter, as it tracks toward 400,000oz gold production by 2029. It also released an updated Investor Presentation.

Codan (ASX: CDA) surged up to 15% to $42/share on Wednesday after reporting it is trading above expectations in 2H FY26, underpinned by strong momentum across its Communications segment and continued robust demand for defence-related technologies. The Company now expects Communications revenue growth at the top end of its 15–20% target range, while bringing forward its 30% segment margin target to FY26. Reflecting this strength, Codan upgraded FY26 guidance to ~A$235M EBIT and ~A$170M NPAT, representing growth of more than 60% on FY25.

Metal Powder Works (ASX: MPW) is on track to meet its target of 800 metric tonnes of installed capacity in 2028 after its NextGen machine achieved sustained production capacity of 100 tonnes per annum, with an in-specification saleable yield exceeding 95% on schedule. Installation of its first additional NextGen unit is targeted for H2 CY26 within its existing facility in Pittsburgh, USA.

Sunshine Metals (ASX: SHN) advanced its gold production plans with a transformational Mt Moss acquisition and $22M capital raising. The deal secures a 300Ktpa processing facility to be converted to gold, with first processing targeted mid-2027. The Mt Moss asset provides existing infrastructure and a clear pathway to production alongside Liontown. Funds will support acquisition, development and working capital as Sunshine moves toward near-term gold production. 

Australian Mines (ASX: AUZ) delivered a strong scoping study for its Flemington Scandium Project in NSW, outlining post-tax NPV of US$270 million at a conservative US$1,500/kg scandium price and US$860 million at a US$3,000/kg sensitivity case. The project features a 28-year mine life, low initial capex of US$125 million and planned annual production of 60 tonnes of high-purity scandium oxide, positioning Flemington as a potentially significant Western scandium supply source. Covered by Stockhead.

C29 Metals (ASX: C29) completed a transformational acquisition, with a binding agreement to acquire 80% of an advanced Namibian copper and gold portfolio, with the right to increase to 90%. The deal is anchored by the advanced Kopermyn Copper Project in the Tier 1 Otavi Copper Belt, where historical drilling has delivered shallow, high-grade copper including 6m @ 4.79% Cu and 12m @ 2.08% Cu, with mineralisation open along strike and at depth. Backed by a A$4.7 million capital raise, the Company is well funded to advance exploration, with drilling expected to commence following approvals in May.

A major commercial milestone for Sparc Technologies (ASX: SPN), with AkzoNobel set to offer an ecosparc® enhanced version of its Interzone® 954 coating in Australia from May 2026. The product, with a +25 year track record across energy, mining and infrastructure, will be the first widely used coating to incorporate ecosparc®, following more than 21 months of testing. The release provides strong validation from a global leader and signals growing adoption of graphene-enhanced materials.

The next investor event bought to you by NWR Communications includes our first Critical Minerals Lunch in Perth. We continue to connect investors with emerging opportunities including the recent Biotech virtual event, which saw a record viewing number and our critical minerals webinar series which continues to be a standout on the calender. 

Date: Wednesday 13st May 

Time: 12:00PM, AWST

Location: Parmelia Hilton Perth

On the latest episode of Vantage Point, AFL legend Leo Barry walks through Fairview Equity Partners’ long history with Codan Limited, from owning it early when the business was more heavily weighted to metal detection, then re-entering years later as the company evolved through strategic acquisitions and built a broader, more diversified platform.

What emerged was a business with strong earnings visibility, greater diversification and a much broader global footprint across communications, defence, and metal detection.

It’s a strong example of conviction, patience, and recognising when a quality business enters its next phase of growth. And the market is clearly paying attention — Codan is up around 15% today, trading at approximately $41/share.

Spotify | YouTube

On the latest episode of Vantage Point Podcast, Scott Kirkland, Co-Founder and CEO of EMVision Medical Devices, joins us to discuss how the company’s portable brain scanner is designed to bring fast, accurate point-of-care diagnosis to the ambulance and to the bedside.

Scott explains the current challenges in stroke care, the importance of faster triage, transfer and treatment decisions and how EMVision’s radio frequency technology is on the journey to enable better outcomes for patients regardless of their location.

We also cover the FDA De Novo pathway, the company’s go-to-market strategy targeting the US Stroke Belt and the broader opportunity to improve access to stroke care in both metropolitan and regional settings.

Spotify | YouTube

East Coast Research initiated coverage on WA Gold (ASX: WAU) with a $0.16 price target, implying ~349% upside to the current share price of $0.04. The report highlighted WA Gold’s flagship Abercromby Project, which hosts a 518koz gold resource at 1.45g/t, with a recently completed scoping study outlining a low-capex development pathway and strong economics.

Canaccord Genuity has reiterated its BUY rating on EQ Resources Limited (ASX: EQR), maintaining a $0.50 price target, implying meaningful upside to the current share price of $0.30. The MarQ’26 report flagged a weaker-than-expected quarter, with production impacted by unusually heavy rainfall at both Barruecopardo and Mt Carbine, particularly at the former where the wettest Q1 in ~50 years constrained access to higher-grade ore and delayed mining activities.

METALS AND MINING

Auric Mining (ASX:AWJ) has set a benchmark in successfully evolving from explorer to producer, building up a record A$46 million in cash and receivables after an outstanding March quarter performance. The highlight was the completion of production at the Munda Starter Pit, which delivered a total of 8,886 ounces of gold, an impressive 46 per cent increase on the original 6,100-ounce budget.  Covered by The Sydney Morning Herald.

American Tungsten & Antimony (ASX: AT4) joined the U.S. Defense Industrial Base Consortium, giving the company direct access to defence supply chain programs and engagement pathways with U.S. government critical minerals initiatives. AT4 said it has also lodged applications for multiple Department of War and Department of Energy funding programs, while planning a government level critical minerals event in Utah on 15 May to showcase its tungsten and antimony strategy. Covered by Stockhead.

Power Minerals (ASX: PNN) completed the acquisition of the high-grade Morro do Ferro Rare Earths Project in Brazil, securing a strategically located asset with strong resource growth potential. Covered by Stockhead & Mining Technology. Following this, it also reported exceptional verification assay results from Morro do Ferro, with duplicate samples confirming grades of up to 14.03% TREO and 2.64% magnet rare earth oxides. The results validate historical drilling data and materially de-risk the project ahead of planned diamond, RC and aircore drilling as Power advances toward a maiden Mineral Resource Estimate. Covered by The Australian.

Many Peaks Minerals (ASX: MPK) reported further strong gold assay results from its ongoing extension and delineation drilling program at the Ferké Gold Project in Côte d’Ivoire. The latest diamond core drill results follow the recent announcement of the inaugural Ouarigue MRE of 26.7Mt @ 1.54g/t gold for 1,323,000 ounces. Covered by Mining.com.au.

Iltani Resources (ASX: ILT) commenced drilling at its Orient silver-indium project in Queensland as its 2026 exploration program kicks off. Iltani is planning to complete 115 RC drillholes for 16,000m at Orient (approximately 30,000m drilled to date in 145 drill holes). First assay results are expected by early June. 

IRIS Metals (ASX: IR1) updated its Mineral Resource Estimate (MRE) to 3.03 million tonnes  at 1.00% Li₂O and 0.116% Rb₂O (Indicated & Inferred) at the Beecher Project in the Black Hills of South Dakota, USA.  This updated MRE defines a lithium resource with a material rubidium component, positioning Beecher as a multi-commodity critical minerals project in the United States and aligned with increasing demand for secure domestic supply. Covered by Stockhead & Hot Copper.

KGL Resources (ASX: KGL) released the results of its Baseline Economic Model (BEM) for the Jervois Copper-Silver-Gold Project in the Northern Territory. The study confirms strong project economics and establishes a solid financial and technical foundation for securing financing and advancing development. The Jervois Project is a high-grade copper resource in Australia, with regulatory and social approvals already in place for development and operations.

Infinity Mining (ASX: IMI) executed a binding farm-in and joint venture agreement with Mining One over its Tanjil Bren and Walhalla South Extended  projects in Victoria.  The agreement represents a key step in advancing Infinity’s Victorian gold–antimony portfolio, providing a funded pathway to progress high-priority exploration targets. Covered by The West Australian

Recharge Metals (ASX: REC) commenced exploration activities at its Sunset Well Gold Project including ground gravity surveys and soil sampling aimed at defining high-priority drill targets along the Prospero and Flanders trends. The company also announced a leadership transition as it moves into a new phase focused on execution and value creation, with experienced geologist Luke Timmermans appointed Chief Executive Officer, with Felicity Repacholi moving into the role of Non-Executive Chair.

Celsius Resources (ASX: CLA) advanced MCB Copper-Gold Project with DFS completed, ~$9.3M raised, and financing process underway. With new MD appointed, momentum builds across development planning, infrastructure & stakeholder engagement, with FID targeted for Q 2026.

Burley Minerals (ASX: BUR) announced that the Heritage Survey is confirmed at the North and Step-Out Targets of its 100%-owned Cane Bore Iron Project for June 2026. The survey will cover the approved reverse circulation drilling at the north and step-out targets.

Locksley Resources (ASX: LKY) advanced rare earth processing pathway work for the Mojave Project in California, USA, with its collaboration with Columbia University progressing across recovery, separation and metallisation aligned to the El Campo REE project in the Mountain Pass region. Covered by Stockhead & The Sydney Morning Herald.

Chariot Resources (ASX: CC9) provided an update on its previously announced proposed acquisition of a 66.667% interest in a Nigerian hard-rock lithium portfolio from Continental Lithium. Covered by Business News and The West Australian.

Alice Queen (ASX: AQX) completed an exploration target estimate for its Horn Island Project in Queensland, highlighting the potential for a large-scale gold mineralised system. Multiple mineralisation zones have been identified, including hard rock vein-hosted gold zones, legacy mine-related stockpiles and tailings, and potential alluvial systems, collectively demonstrating a substantial target and reinforcing large-scale potential. An updated Mineral Resource Estimate (MRE) and Scoping Study are progressing in parallel to evaluate a potential mine restart and near-term development opportunities. Covered by Mining.com.au.

INDUSTRIAL

Babylon Pump & Power (ASX: BPP) reported on a March quarter that featured continued strong demand in Babylon’s rental segment, with improving utilisation and earnings quality as Babylon executes its strategy to build a scaled, high-margin water management platform.

CONSUMER

BPH Global (ASX: BP8) reported a strong rebound in its eleventh month of seaweed trading as seasonal conditions improve. Gross sales reached IDR 4,215,000,000 (~A$369,737), up 68.1% month-on-month, with aggregate sales of ~A$2.94 million over the first eleven months of operations. Covered by StockWire X.  It also announced the appointment of Ifat Mazouz as Chief Scientific Officer, effective 25 May 2026. Ms Mazouz transitions from her role on the Company’s Advisory Board to lead R&D programs, with a focus on aligning research activities to commercial pathways and execution. Covered by Stockwire X.

TECHNOLOGY

Etherstack (ASX:ESK) delivered a strong FY26 trading update, guiding to record first-half revenue of US$7.6–8.5 million and upgrading its full-year expectations, driven by solid progress on major government contracts in the US, UK, and Australia plus recent new wins. Highlighting robust delivery momentum and a healthy contract backlog heading into the second half, reinforcing confidence in continued growth across its defence and public safety markets.

Swift TV (ASX: STV) announced that the commercial rollout of its new Swift TV product is accelerating, reporting also on a cash flow positive quarter.

BIOTECH

Chimeric Therapeutics (ASX: CHM) reported encouraging Phase 1B data for its CORE-NK cell therapy in frontline high risk acute myeloid leukaemia, with 60% of the first 25 patients achieving complete response or complete response with incomplete count recovery. The trial, being conducted at MD Anderson Cancer Center, combines CHM CORE-NK with standard of care therapies and has shown no unexpected safety issues, with enrolment continuing.

Syntara (ASX: SNT) received positive feedback from the FDA, which has backed the proposed Phase 2b trial design for lead asset amsulostat, clearing the path for late-stage development in myelofibrosis. The planned ~100-patient placebo-controlled study will test amsulostat alongside standard JAK inhibitor therapy, with symptom reduction as the primary endpoint. The company said the positive Type C meeting outcome strengthens amsulostat’s commercial positioning and supports partnering discussions. Syntara also flagged multiple 2026 catalysts, including interim MDS trial data, topline Parkinson’s-related Phase 2 results and skin scarring study updates. Covered by ShareCafe and Business News Australia.

Saluda Medical (ASX: SLD) delivered strong Q3 FY26 momentum, with revenue rising 34% to US$23.8M, supported by continued expansion of its US sales force, growing physician adoption and increasing utilisation. The Company upgraded FY26 revenue guidance to US$87M, reflecting confidence in sustained commercial execution and demand across key markets. Ongoing rollout of its EVA™ platform and increasing clinical validation continue to underpin scalable growth. Saluda will host an investor webinar today at 10.30am AEST - register HERE.

Emyria (ASX: EMD) expands into NSW with new Sydney Empax clinic, growing to 5 sites nationally and increasing treatment capacity. Authorised Prescriber network doubles, supporting continued growth in advanced mental health therapies. Covered by StockWire X.

Paradigm Biopharmaceuticals (ASX: PAR) provided an update on its pivotal Phase 3 PARA_OA_012 clinical trial, including completion of a planned Data Safety Monitoring Board (DSMB) safety review and continued site expansion to support the final phase of recruitment. The independent DSMB has completed a planned safety review of approximately the first 20% of participants who have completed dosing (Day 39) in the PARA_OA_012 study. Following this review, the trial will continue to the 100% recruitment milestone of approximately 466 participants.

Additionally, Paradigm Chief Medical Officer Dr Donna Skerrett, delivered a theatre presentation at the 2026 Osteoarthritis Research Society International Congress, in Florida, United States. The presentation detailed results from the Company’s Phase 2 clinical trial, PARA_OA_008, evaluating injectable pentosan polysulfate sodium (iPPS) in patients with knee osteoarthritis (OA), including those with Kellgren-Lawrence (KL) radiographic grades 2, 3 and 4.

ECS Botanics (ASX: ECS) announced its first commercial oil shipment to New Zealand amidst new product launches and its third consecutive quarter of positive operating cash flow. Covered by Cannabiz.

Imricor Medical Systems (ASX: IMR) released its Q1 CY26 Quarterly Activities Report, highlighting accelerating regulatory momentum. The company received FDA clearance for NorthStar® and the Vision-MR® Diagnostic Catheter in January, submitted the Advantage-MR System for FDA 510(k) clearance, and filed NorthStar for paediatric label expansion. Imricor expanded its VISABL-AFL and VISABL-VT clinical trials, adding three high-volume hospital sites. The company held total cash and short-term investments of US$32.9m at 31 March 2026.

CORPORATE NEWS

Syntara (ASX: SNT) secured firm commitments to raise A$8 million through a two-tranche placement and plans a further A$2 million share purchase plan, following positive FDA feedback on its lead myelofibrosis drug candidate amsulostat. Proceeds will fund five clinical trial readouts in 2026, licensing discussions and Phase 2b trial preparation, extending the company’s cash runway to Q3 2027.

Paradigm Biopharmaceuticals (ASX: PAR) successfully completed a $14.0m Placement to institutional and sophisticated investors, together with a Share Purchase Plan to eligible shareholders to raise up to an additional $2.0m, strengthening the Company’s balance sheet and providing funding flexibility through the upcoming interim analysis and into the post-interim period.

Kalamazoo Resources (ASX: KZR) appointed BurnVoir Corporate Finance as Financial Adviser to support the advancement of its 1.44Moz Ashburton Gold Project. The appointment represents an important step as the Ashburton Gold Project progresses through PFS & toward development. Covered by Mining.com.au.

American Tungsten & Antimony (ASX: AT4) established a sponsored Level 1 ADR program with Deutsche Bank under ticker ATAYY, creating a framework for U.S. investor participation ahead of its proposed Nasdaq listing targeted for Q2 2026. The move gives U.S. institutional and retail investors potential USD-denominated access to AT4 through standard brokerage platforms, supporting the company’s U.S.-focused critical minerals strategy.

Auric Mining (ASX:AWJ) appointed Gareth Solly as Chief Executive Officer and Executive Director, effective 18 May 2026 with a planned transition to Managing Director on 1 December 2026. Founder and current Managing Director Mark English will remain as Executive and Finance Director, supporting a smooth transition and ongoing financial discipline. Gareth is a proven mining executive with 20 years’ experience in the Western Australian gold sector, most recently serving as founding Managing Director of Black Cat Syndicate (ASX: BC8), where he grew the company from a ~$6m exploration IPO into a ~100,000ozpa multi-asset gold producer with a 2.5Moz resource base.

Strata Minerals (ASX: SMX) secured firm commitments to raise A$1.57 million through an equity placement at A$0.02 per share, backed by strong support from existing shareholders and sophisticated investors. The funds will be used to accelerate exploration, advance resource definition, and support key strategic initiatives at the Zelica Gold Project, with Phase 2 drill assay results expected in the coming weeks.  Covered by Stockhead and Finance News Network.

Evergold Minerals (ASX: EG1) secured a drilling grant under the WA Government’s Exploration Incentive Scheme  (EIS) for the newly defined Gladiator Prospect. The Grant will co-fund EG1’s targeted diamond drilling program designed to test the interpreted intrusive source at depth beneath the Gladiator gold-in-soil and gravity anomaly. Covered by The Market Bull.

Arovella Therapeutics (ASX: ALA) appointed four new Directors to its Board as part of its broader succession strategy to identify suitable candidates to complement the expertise currently represented on the Board.

Time to Leverage Up: The Nexalis (ASX: NX1) Story - Coverage by Jason Segal

FireBrick Pharma (ASX: FRE) - Biotech Daily feature by Tim Boreham

Cue Energy (ASX: CUE) Secures Major Gas Deal, Addresses Takeover Bid in Q3 Report - Covered by Finance News Network

Lincoln Minerals (ASX: LML) reaching for direct market engagement: RIU Sydney

East Coast believes WA Gold’s (ASX: WAU) near-term catalysts and strategic position offer 344pc upside

Syntara (ASX: SNT) Equity Raising Presentation

Sunshine Metals (ASX: SHN) Presentation: Mt Moss Acquisition & Growth Plan

CurveBeam (ASX: CVB) Quarterly Results Presentation

Ben Pollard on the new strategy for WA Gold (ASX: WAU) formerly BMG Resources - Interview with Kerry Stevenson at Making Money Matter

Long Shortz with WA Gold (ASX: WAU): Abercromby study maps path to early gold production

IRIS Metals (ASX: IR1) US Operations President Matt Hartman spoke with Barry FitzGerald on Stockhead’s The Explorers Podcast following announcement of the company’s  upgraded mineral resource at the Beecher lithium project in South Dakota, which now includes a high-grade rubidium component, believed to be the first US mineral resource containing rubidium.

Many Peaks Minerals (ASX: MPK) Managing Director Travis Schwertfeger joined SmithWeekly Research to discuss the latest updates, including the newly released maiden mineral resource estimate and ongoing drilling activities at the Ferké gold project  in Cote d’Ivoire.

AuKing Mining (ASX: AKN) Investor Webinar Replay: Tundulu REE Acquisition

Australian Mines Ltd (ASX: AUZ) Flemington Scoping Study Webinar Replay

Larvotto Resources (ASX: LRV) Managing Director Ron Heeks presented at the Ignite Conference in Hong Kong